InvestorsHub Logo
Followers 2
Posts 476
Boards Moderated 0
Alias Born 10/18/2017

Re: None

Monday, 04/13/2020 7:14:56 PM

Monday, April 13, 2020 7:14:56 PM

Post# of 34626
Joy Patient #12 in pancreatic trial could be the 2nd person in complete remission. He or she was going to receive 3 more MutliTaa treatments at the end of 2019 and in January and February 2020. 40% of the tumor has been dissolved by the 1st three months of MultiTAA treatment. The company already knows what the results are and will be sharing this information in the 3rd quarter this year. They have been adding staff so I take that they know they can get additional funding and have the goods. I am hopeful for a partnership with someone like Merck where they pay for additional trials for pancreatic cancer and we give them a percentage of future revenue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News